1 |
Baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 5件: 2 , 10, 13, 18, 149 💬 |
2 |
Binocrit*1sir 40000ui/1ml |
- |
- |
- |
- |
018 1件: 18 💬 |
3 |
Bupropion |
Bupropion |
3件: D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 5件: 8 , 18, 21, 96, 171 💬 |
4 |
Bupropion & citalopram |
Bupropion |
5件: D00817 D00817, D00822 D00822, D07591 D07591, D07704 D07704, D07938 D07938 💬 |
SLC6A2 3件: SLC6A2, SLC6A3, SLC6A4 💬 |
Alcoholism 8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle |
018 1件: 18 💬 |
5 |
Butylphthalide |
Butylphthalide |
- |
- |
- |
002 4件: 2 , 6 , 18, 22 💬 |
6 |
C-trelin od tab(5mg taltirelin hydrate) |
- |
- |
- |
- |
018 1件: 18 💬 |
7 |
Cabaletta |
Trehalose |
- |
- |
- |
018 2件: 18, 113 💬 |
8 |
Cabaletta for iv infusion once weekly during 24 weeks |
Trehalose |
- |
- |
- |
018 1件: 18 💬 |
9 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
10 |
Citalopram |
Citalopram |
2件: D00822 D00822, D07704 D07704 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
11 |
Coenzyme q10 |
Ubidecarenone |
1件: D01065 D01065 💬 |
- |
- |
002 12件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
12 |
Cti-1601 |
- |
- |
- |
- |
018 1件: 18 💬 |
13 |
Deferiprone |
Deferiprone |
1件: D07416 D07416 💬 |
- |
- |
002 6件: 2 , 6 , 18, 120, 122, 233 💬 |
14 |
Egb 761 (r) 120 mg |
- |
- |
- |
- |
018 1件: 18 💬 |
15 |
Egb 761 120 mg |
- |
- |
- |
- |
018 1件: 18 💬 |
16 |
Epoeitin beta |
- |
- |
- |
- |
018 1件: 18 💬 |
17 |
Epoetin alfa |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 3件: 13, 18, 46 💬 |
18 |
Eprex*1fl 40000ui/ml 1ml |
- |
- |
- |
- |
018 1件: 18 💬 |
19 |
Eprex*1sir 10000ui 1ml |
- |
- |
- |
- |
018 1件: 18 💬 |
20 |
Eprex*1sir 40000ui/ml 1ml |
- |
- |
- |
- |
002 2件: 2 , 18 💬 |
21 |
Erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 9件: 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
22 |
Etravirine |
Etravirine |
1件: D04112 D04112 💬 |
- |
- |
018 1件: 18 💬 |
23 |
Etravirine tablets |
Etravirine |
1件: D04112 D04112 💬 |
- |
- |
018 1件: 18 💬 |
24 |
Eu1/97/031-032 |
- |
- |
- |
- |
018 1件: 18 💬 |
25 |
Eu1/97/031/031-032 |
- |
- |
- |
- |
018 1件: 18 💬 |
26 |
Flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 5件: 6 , 13, 17, 18, 206 💬 |
27 |
Gamma interferon |
- |
- |
- |
- |
018 1件: 18 💬 |
28 |
Ginkgo |
Ginkgo biloba |
- |
- |
- |
006 4件: 6 , 13, 18, 90 💬 |
29 |
Ginkgo biloba |
Ginkgo biloba |
- |
- |
- |
013 3件: 13, 18, 90 💬 |
30 |
Granocyte |
- |
- |
- |
- |
018 2件: 18, 57 💬 |
31 |
H-116pi-de.pdf |
- |
- |
- |
- |
018 1件: 18 💬 |
32 |
High-dose intravenous immunoglobulin (ivig) |
- |
- |
- |
- |
018 1件: 18 💬 |
33 |
Idebenone |
Idebenone |
1件: D01750 D01750 💬 |
- |
- |
006 5件: 6 , 13, 18, 113, 302 💬 |
34 |
Imukin*sc 6f 0,5ml 100mcg |
- |
- |
- |
- |
018 1件: 18 💬 |
35 |
Interferon gamma |
Interferon Gamma |
- |
- |
- |
018 8件: 18, 65, 85, 107, 228, 299, 301, 326 💬 |
36 |
Interferon gamma-1b |
Interferon Gamma |
1件: D00747 D00747 💬 |
IFNGR1 2件: IFNGR1, IFNGR2 💬 |
Chagas disease 18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
018 7件: 18, 65, 85, 228, 299, 301, 326 💬 |
37 |
Iron |
Iron |
- |
- |
- |
018 5件: 18, 96, 97, 254, 284 💬 |
38 |
Iron chelating intervention |
Iron |
- |
- |
- |
018 1件: 18 💬 |
39 |
Kps-0373 |
- |
- |
- |
- |
018 1件: 18 💬 |
40 |
Kps-0373, high dose |
- |
- |
- |
- |
018 1件: 18 💬 |
41 |
Kps-0373, low dose |
- |
- |
- |
- |
018 1件: 18 💬 |
42 |
Lenograstim |
Lenograstim |
1件: D03247 D03247 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 7件: 2 , 13, 16, 18, 19, 57, 65 💬 |
43 |
Lithium carbonate |
Carbonate ion |
1件: D00801 D00801 💬 |
- |
- |
002 6件: 2 , 13, 17, 18, 19, 127 💬 |
44 |
Lu aa24493 |
- |
- |
- |
- |
018 1件: 18 💬 |
45 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
46 |
Min-102 |
- |
- |
- |
- |
018 2件: 18, 20 💬 |
47 |
Neo-recormon |
- |
- |
- |
- |
018 1件: 18 💬 |
48 |
Neorecormon |
- |
- |
- |
- |
013 2件: 13, 18 💬 |
49 |
Nicotinamide |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
002 6件: 2 , 6 , 18, 49, 162, 191 💬 |
50 |
Nicotinamide riboside |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
002 4件: 2 , 6 , 18, 191 💬 |
51 |
Omaveloxolone |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
52 |
Omaveloxolone capsules, 10 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
53 |
Omaveloxolone capsules, 150 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
54 |
Omaveloxolone capsules, 160 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
55 |
Omaveloxolone capsules, 2.5 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
56 |
Omaveloxolone capsules, 20 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
57 |
Omaveloxolone capsules, 300 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
58 |
Omaveloxolone capsules, 40 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
59 |
Omaveloxolone capsules, 5 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
60 |
Omaveloxolone capsules, 80 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
61 |
Other: exercise intervention |
- |
- |
- |
- |
013 2件: 13, 18 💬 |
62 |
Resveratrol |
Resveratrol |
- |
- |
- |
002 6件: 2 , 8 , 18, 89, 113, 299 💬 |
63 |
Rhug-csf |
- |
- |
- |
- |
018 1件: 18 💬 |
64 |
Riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
65 |
Riluzole pmcs |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
018 1件: 18 💬 |
66 |
Rokan (r) novo 120 mg |
- |
- |
- |
- |
018 1件: 18 💬 |
67 |
Rosuvastatin |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
68 |
Standardized ginkgo biloba extract (egb 761 (r) |
Ginkgo biloba |
- |
- |
- |
018 1件: 18 💬 |
69 |
Sub09246mig |
- |
- |
- |
- |
018 1件: 18 💬 |
70 |
Tak-831 |
TAK-831 |
- |
- |
- |
018 1件: 18 💬 |
71 |
Varenicline |
Varenicline |
1件: D08669 D08669 💬 |
CHRNA4 2件: CHRNA4, CHRNB2 💬 |
Cholinergic synapse 3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction |
006 2件: 6 , 18 💬 |
72 |
Vatiquinone |
Vatiquinone |
1件: D10407 D10407 💬 |
- |
- |
018 2件: 18, 21 💬 |